TickerFacts.

InMode Ltd. (INMD): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

$86.08M
Year ended 2025-12-31
-24.3%
3-year compound annual growth
+3.3%
5-year compound annual growth
$198.53M2017-12-31: $9.15M2018-12-31: $23.67M2019-12-31: $59.92M2020-12-31: $73.26M2021-12-31: $167.99M2022-12-31: $198.53M2023-12-31: $196.28M2024-12-31: $113.26M2025-12-31: $86.08M$86.08M
2017-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$86.08M-24.0%2026-02-10, From 2025-01-01
2024-12-31$113.26M-42.3%2026-02-10, From 2024-01-01
2023-12-31$196.28M-1.1%2026-02-10, From 2023-01-01
2022-12-31$198.53M+18.2%2025-02-04, From 2022-01-01
2021-12-31$167.99M+129.3%2024-02-13, From 2021-01-01
2020-12-31$73.26M+22.3%2023-02-14, From 2020-01-01
2019-12-31$59.92M+153.1%2022-02-10, From 2019-01-01
2018-12-31$23.67M+158.6%2021-02-10, From 2018-01-01
2017-12-31$9.15Mn/a2020-02-18, From 2017-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
InMode Ltd. (INMD)2025-12-31$86.08M-24.0%
TransMedics Group, Inc. (TMDX)2025-12-31$135.77M+137.1%
Axogen, Inc. (AXGN)2025-12-31-$1.19Mn/m
Outset Medical, Inc. (OM)2025-12-31-$62.37Mn/m
Biolife Solutions Inc (BLFS)2025-12-31-$14.35Mn/m
Vaso Corp (VASO)2025-12-31-$2.03Mn/m
Ceribell, Inc. (CBLL)2025-12-31-$57.06Mn/m
Integer Holdings Corp (ITGR)2025-12-31$351.93M+10.2%
Iridex Corp (IRIX)2026-01-03-$2.05Mn/m

Compare INMD, TMDX, AXGN, OM side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗